{"@id":"https://bioecon.ru/technology/urolithin-a-mitophagy-nutraceuticals/","@type":"Technology","cluster":"specialty-fine-chem","formats":{"html":"https://bioecon.ru/technology/urolithin-a-mitophagy-nutraceuticals/","json":"https://bioecon.ru/api/v1/technology/urolithin-a-mitophagy-nutraceuticals/index.json"},"id":"urolithin-a-mitophagy-nutraceuticals","industries":["longevity"],"lang":"ru","links":{"industries":["https://bioecon.ru/industries/longevity/"],"suppliers":["https://bioecon.ru/companies/amazentis/","https://bioecon.ru/companies/shenzhen-hygieia-biotech/","https://bioecon.ru/companies/activ-inside/","https://bioecon.ru/companies/kemin-industries/","https://bioecon.ru/companies/algalif/","https://bioecon.ru/companies/anagenix/","https://bioecon.ru/companies/benexia/","https://bioecon.ru/companies/keraplast/","https://bioecon.ru/companies/genera-dd/","https://bioecon.ru/companies/lignopure-gmbh/"]},"maturity":7,"name":"Уролитин A и нутрицевтики для митофагии","regions":["us","eu"],"risk":"medium","section":"technology","sector":"biochem-industrial","sources":[{"date":"2026-11-09","entity":"amazentis.com","kind":"web","urls":["https://www.amazentis.com/"]},{"date":"2026-11-09","entity":"pmc.ncbi.nlm.nih.gov","kind":"research","urls":["https://pmc.ncbi.nlm.nih.gov/articles/PMC13492243/"]},{"date":"2026-11-09","entity":"mitopure.com","kind":"web","urls":["https://www.mitopure.com/"]}],"stages":[{"n":1,"title":"Закупить ингредиент"},{"n":2,"title":"Получить разрешение"},{"n":3,"title":"Подтвердить заявление"}],"summary":"Постбиотический ингредиент для поддержки митохондрий, на рынке с июля 2020 года; ключевые препятствия — разрешение как нового пищевого продукта и данные о долгосрочной безопасности.","url":"/technology/urolithin-a-mitophagy-nutraceuticals/","verified":"2026-11-09"}